Advertisement

Acute phase reactants in Alzheimer's disease

      This paper is only available as a PDF. To read, Please Download here.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abraham C
        The role of the acute phase protein alpha 1 antichymotrypsin in brain dysfunction and injury.
        Res Immunol. 1992; 143: 631-636
        • Abraham CR
        • Selkoe DJ
        • Potter H
        Immunochemical identification of the serine protease inhibitor alpha 1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.
        Cell. 1988; 52: 487-501
        • Altstiel LD
        • Lawlor BA
        • Mohs RC
        • Schmeidler J
        • Dalbn A
        • Mehta P
        • Davis KL
        Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer disease patients.
        Dementia. 1995; 6 (1995): 17-20
        • Brugge K
        • Katzman R
        • Hill LR
        • Hansen LA
        • Saitoh T
        Serological alpha 1 antichymotrypsin in Down's syndrome and Alzheimer's disease.
        Ann Neurol. 1992; 32: 192-197
        • Folstein MF
        • Folstein ME
        • McHugh PR
        Mini-mental state: A practical method for grading the cognitive state of patients for the clinician.
        J Psychiat Res. 1975; 12: 189-198
        • Hinds TR
        • Kukull WA
        • Van Belle G
        • Schellenberg GD
        • Villacres EC
        • Larson EB
        The relationship between serum alpha 1 antichymotrypsin and Alzheimer's disease.
        Neurobiol Aging. 1994; 15: 21-27
        • Hughes CP
        • Berg L
        • Danziger WL
        • Coben LA
        • Martin RL
        A new clinical scale for the staging of dementia.
        Br J Psychiatry. 1982; 140: 566-572
        • Kuiper MA
        • Van Kamp GJ
        • Bergmans PLM
        • Scheltens P
        • Wolters EC
        Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.
        J Neural Transm. 1993; 6: 145-149
        • McKhann G
        • Drachman D
        • Folstein M
        • Katzman R
        • Price D
        • Stadlan EM
        Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group.
        Neurology. 1984; 34: 939-944
        • Matsubara E
        • Amari M
        • Shoji M
        • et al.
        Significance of measurement of serum alpha 1 antichymotrypsin in senile dementia of the Alzheimer type.
        J Clin Exp Med. 1988; 145: 907-908
        • Matsubara E
        • Hirai S
        • Amari M
        • et al.
        Alpha 1 antichymotrypsin as a possible biochemical marker for Alzheimer type dementia.
        Ann Neurol. 1990; 28: 561-567
        • Rozemueller JM
        • Eikelboom P
        Acute phase proteins are present in amorphous plaques in the cerebral cortex but not in cerebellar cortex of patients with Alzheimer's disease.
        Neurosci Lett. 1990; (1991): 75-78